Quantcast
Last updated on April 16, 2014 at 14:14 EDT

Latest Vagus nerve stimulation Stories

2014-04-11 08:24:20

DUBLIN, April. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kjxvb2/nerve_repair_and ) has announced the addition of the "Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - Global Trend & Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) This report categorizes the market into the peripheral nerve repair segment and the neuromodulation segment....

2014-04-09 12:31:15

New Indications and Demand for Replacement Devices Will Drive Market Expansion, According to Findings from Decision Resources Group BURLINGTON, Mass., April 9, 2014 /PRNewswire/ -- Decision Resources Group finds that the approval of new indications--particularly chronic heart failure, obesity and epilepsy--will expand the patient pool and market potential for neurostimulation devices in the United States considerably, allowing the market to reach a value approaching $4 billion by 2022. Most...

2014-03-08 23:01:21

The global nerve repair and regeneration market is segmented into peripheral nerve repair and neuromodulation segments. http://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html (PRWEB) March 08, 2014 The “Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to...

2014-02-28 23:31:41

Atlantic NeuroSurgical Specialists’ (ANS) neurosurgeon, Dr Zampella, discusses new treatment options for chronic neurosurgical illnesses within functional neurosurgery. Morristown, NJ (PRWEB) February 28, 2014 Atlantic NeuroSurgical Specialists (ANS) announced today advanced treatment options for their patients through Functional neurosurgery. Functional neurosurgery consists of new and innovative procedures used to treat chronic illnesses such as epilepsy, spasticity, pain, and...

2014-02-20 08:29:34

Proprietary Technology Provides Automatic Stimulation upon Seizure Detection HOUSTON, Feb. 20, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator. The AspireSR generator provides the well-established benefits of VNS Therapy, coupled with a new feature - Automatic Stimulation in response to detection of a seizure. Proprietary...

2014-02-19 16:24:40

HOUSTON, Feb. 19, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Greg Browne, Cyberonics' Chief Financial Officer, will participate in one-on-one meetings with investors during the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, February 25, 2014. No formal presentation is scheduled, and the one-on-one...

2014-02-05 20:27:03

DUBLIN, February 6, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7qltb7/nerve_repair_and) has announced the addition of the "Nerve Repair & Regeneration Market - Forecast to 2018" [http://www.researchandmarkets.com/research/7qltb7/nerve_repair_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report categorizes the market into the peripheral nerve repair segment and the...

2014-01-29 23:04:02

The new program will include brain ‘pacemakers’, specialized women’s care, and in-patient monitoring. Hopewell, NJ (PRWEB) January 29, 2014 The Capital Institute for Neurosciences (CIN) today announced it has launched a new program to provide highly specialized care for patients with epilepsy and other seizure disorders. The CIN Epilepsy and Seizure Disorders Program at Capital Health provides patients with state-of-the-art testing and evaluation, including 24-hour continuous...

2014-01-29 23:03:18

Technological advancements and the consequent development of devices catering to niche disease segments such as migraine and epilepsy expected to drive this market. Visit http://www.grandviewresearch.com/industry-analysis/neurostimulation-devices-industry. San Francisco, California (PRWEB) January 29, 2014 The global market for neurostimulation devices is expected to reach USD 8,791.8 million by 2020, according to a new study by Grand View Research, Inc. The presence of high unmet medical...

2014-01-10 23:03:41

The global nerve repair and regeneration market is segmented into peripheral nerve repair and neuromodulation segments. http://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html (PRWEB) January 10, 2014 The “Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to...